Cengent Therapeutics

Cengent Therapeutics Inc. was acquired by Metabasis Therapeutics Inc. Cengent Therapeutics, Inc. is a drug discovery company. It has preclinical programs in obesity/diabetes, anti-infectives, oncology, and inflammation. The company also offers "Gene-to-Lead" technology, a technology that accelerates and validates lead discovery; structurebank, a comparative analysis database of protein targets and anti-targets; and structure determination services, including enhanced homology modeling and X-ray crystallography, to accelerate and optimize the drug discovery process. Cengent Therapeutics, Inc. was formerly known as Structural Bioinformatics Inc. The company was founded in 1996 and is headquartered in San Diego, California, with additional offices in Cambridge, Massachusetts, Washington, Harrisburg, Pennsylvania, and Copenhagen, Denmark.